Stevanato Group (NYSE:STVN) Updates FY24 Earnings Guidance

Stevanato Group (NYSE:STVN) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of €0.47-0.49 for the period, compared to the consensus earnings per share estimate of $0.48. The company issued revenue guidance of €1.09-1.11 billion, compared to the consensus revenue estimate of $1.09 billion. Stevanato Group also updated its FY 2024 guidance to 0.517-0.539 EPS.

Stevanato Group Trading Up 0.2 %

Stevanato Group stock traded up €0.05 ($0.05) during mid-day trading on Wednesday, reaching €22.55 ($24.78). 669,300 shares of the company were exchanged, compared to its average volume of 511,327. The company has a fifty day simple moving average of €19.61 and a 200-day simple moving average of €20.30. Stevanato Group has a 12 month low of €16.56 ($18.20) and a 12 month high of €34.73 ($38.16). The company has a debt-to-equity ratio of 0.19, a current ratio of 1.74 and a quick ratio of 1.13.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings data on Tuesday, August 6th. The company reported €0.09 ($0.10) EPS for the quarter, missing analysts’ consensus estimates of €0.10 ($0.11) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 10.89% and a net margin of 11.27%. The company had revenue of €259.60 million for the quarter, compared to the consensus estimate of €254.92 million. During the same quarter last year, the business earned $0.15 EPS. Stevanato Group’s revenue was up 1.7% on a year-over-year basis. As a group, equities analysts anticipate that Stevanato Group will post 0.5 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on STVN. Morgan Stanley decreased their price target on Stevanato Group from $26.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Monday, July 15th. Citigroup decreased their price target on Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a research note on Wednesday, August 7th.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.